LeBlanc, Michel meet with pharma sector as U.S. buckles down on cutting drug prices

United States President Donald Trump’s efforts to reset how pharmaceutical firms negotiate drug prices with his government—and the consequences for countries including Canada—were recently discussed at an in-person meeting between pharmaceutical representatives, Canada...
Get Today's Headlines Newsletter
Wake up to the day's top political and policy headlines. Weekday Mornings.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy






